PFM
DRTSW icon

Privium Fund Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Privium Fund Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,000
Closed -$33K – 271
2022
Q1 		$33K Buy
+54,000
New +$29.5K 0.01% 175

Other funds holding DRTSW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return

Privium Fund Management's DRTSW Position: Q2 2022 in Review

Privium Fund Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2022, closing a stake of 54,000 shares — an estimated $33K sold.

Privium Fund Management first reported a position in DRTSW in Q1 2022 and held it in 1 quarter. The position peaked at $33K in Q1 2022. 37 funds tracked by Wall St. Rank hold DRTSW as of Q2 2022.

  • Privium Fund Management reported no remaining Alpha Tau Medical Warrant position as of Q2 2022 after selling out during the quarter.
  • Privium Fund Management sold 54,000 Alpha Tau Medical Warrant shares in Q2 2022, an estimated $33K.
  • Privium Fund Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 1 quarter.
  • Privium Fund Management's Alpha Tau Medical Warrant position peaked at $33K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2022.

Based on Privium Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.